SELLAS Life Sciences Grou...

NASDAQ: SLS · Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Aug 15, 2025, 3:59 PM
1.63
0.62%
After-hours: Aug 15, 2025, 04:06 PM EDT

SELLAS Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-30.88M -37.34M -41.3M -20.7M
Depreciation & Amortization
n/a n/a 457K 5.68M
Stock-Based Compensation
1.56M 1.39M 1.73M 1.01M
Other Working Capital
-4.51M 1.04M 4.43M -5.1M
Other Non-Cash Items
561K 1.2M 10.13M -4.16M
Deferred Income Tax
n/a n/a -457K -239K
Change in Working Capital
-6.65M 3.35M 5.64M -7.62M
Operating Cash Flow
-35.4M -31.41M -23.81M -26.02M
Capital Expenditures
n/a -5.5M -4.5M n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a -5.5M -4.5M n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
594K 90K 85K 3.07M
Financial Cash Flow
46.76M 22.32M 24.08M 12.07M
Net Cash Flow
11.36M -14.6M -4.23M -13.95M
Free Cash Flow
-35.4M -36.91M -28.31M -26.02M